Fingerprint
Dive into the research topics of 'First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically